BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 23727341)

  • 1. Targeting C-type lectin receptors with multivalent carbohydrate ligands.
    Lepenies B; Lee J; Sonkaria S
    Adv Drug Deliv Rev; 2013 Aug; 65(9):1271-81. PubMed ID: 23727341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A platform to screen for C-type lectin receptor-binding carbohydrates and their potential for cell-specific targeting and immune modulation.
    Maglinao M; Eriksson M; Schlegel MK; Zimmermann S; Johannssen T; Götze S; Seeberger PH; Lepenies B
    J Control Release; 2014 Feb; 175():36-42. PubMed ID: 24368301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological evaluation of multivalent lewis X-MGL-1 interactions.
    Eriksson M; Serna S; Maglinao M; Schlegel MK; Seeberger PH; Reichardt NC; Lepenies B
    Chembiochem; 2014 Apr; 15(6):844-51. PubMed ID: 24616167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-type lectins on dendritic cells: key modulators for the induction of immune responses.
    van Kooyk Y
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1478-81. PubMed ID: 19021579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From structure to function - Ligand recognition by myeloid C-type lectin receptors.
    Fischer S; Stegmann F; Gnanapragassam VS; Lepenies B
    Comput Struct Biotechnol J; 2022; 20():5790-5812. PubMed ID: 36382179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation.
    van Kooyk Y; Unger WW; Fehres CM; Kalay H; García-Vallejo JJ
    Mol Immunol; 2013 Sep; 55(2):143-5. PubMed ID: 23158834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting DC-SIGN with carbohydrate multivalent systems.
    Sánchez-Navarro M; Rojo J
    Drug News Perspect; 2010 Nov; 23(9):557-72. PubMed ID: 21152451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous ligands for C-type lectin receptors: the true regulators of immune homeostasis.
    García-Vallejo JJ; van Kooyk Y
    Immunol Rev; 2009 Jul; 230(1):22-37. PubMed ID: 19594627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycan-Based Cell Targeting To Modulate Immune Responses.
    Johannssen T; Lepenies B
    Trends Biotechnol; 2017 Apr; 35(4):334-346. PubMed ID: 28277249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin.
    Galustian C; Park CG; Chai W; Kiso M; Bruening SA; Kang YS; Steinman RM; Feizi T
    Int Immunol; 2004 Jun; 16(6):853-66. PubMed ID: 15136555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexible Signaling of Myeloid C-Type Lectin Receptors in Immunity and Inflammation.
    Del Fresno C; Iborra S; Saz-Leal P; Martínez-López M; Sancho D
    Front Immunol; 2018; 9():804. PubMed ID: 29755458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel insights into the immunomodulatory role of the dendritic cell and macrophage-expressed C-type lectin MGL.
    van Kooyk Y; Ilarregui JM; van Vliet SJ
    Immunobiology; 2015 Feb; 220(2):185-92. PubMed ID: 25454488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DC-SIGN mediated antigen-targeting using glycan-modified liposomes: formulation considerations.
    Joshi MD; Unger WW; van Beelen AJ; Bruijns SC; Litjens M; van Bloois L; Kalay H; van Kooyk Y; Storm G
    Int J Pharm; 2011 Sep; 416(2):426-32. PubMed ID: 21371544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells.
    Unger WW; van Beelen AJ; Bruijns SC; Joshi M; Fehres CM; van Bloois L; Verstege MI; Ambrosini M; Kalay H; Nazmi K; Bolscher JG; Hooijberg E; de Gruijl TD; Storm G; van Kooyk Y
    J Control Release; 2012 May; 160(1):88-95. PubMed ID: 22366522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Characterization of Carbohydrate-Based Adjuvants.
    Johannssen T; Lepenies B
    Methods Mol Biol; 2015; 1331():173-87. PubMed ID: 26169741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailoring the immune response by targeting C-type lectin receptors on alveolar macrophages using "pathogen-like" amphiphilic polyanhydride nanoparticles.
    Chavez-Santoscoy AV; Roychoudhury R; Pohl NL; Wannemuehler MJ; Narasimhan B; Ramer-Tait AE
    Biomaterials; 2012 Jun; 33(18):4762-72. PubMed ID: 22465338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses.
    van Vliet SJ; García-Vallejo JJ; van Kooyk Y
    Immunol Cell Biol; 2008 Oct; 86(7):580-7. PubMed ID: 18679407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self- and nonself-recognition by C-type lectins on dendritic cells.
    Geijtenbeek TB; van Vliet SJ; Engering A; 't Hart BA; van Kooyk Y
    Annu Rev Immunol; 2004; 22():33-54. PubMed ID: 15032573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sweet preferences of MGL: carbohydrate specificity and function.
    van Vliet SJ; Saeland E; van Kooyk Y
    Trends Immunol; 2008 Feb; 29(2):83-90. PubMed ID: 18249034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid C-Type Lectin Receptors in Viral Recognition and Antiviral Immunity.
    Monteiro JT; Lepenies B
    Viruses; 2017 Mar; 9(3):. PubMed ID: 28327518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.